New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 29, 2014
07:46 EDTSNN, SYKStryker risk/reward favorable, says RBC Capital
After Financial Times reported that Stryker (SYK) was preparing a bid for Smith & Nephew (SNN), RBC Capital thinks the deal would be 8%-10% accretive in the first year and 15%-20% accretive in the third year. The firm thinks that Stryker's stock can rise further from current levels.
News For SYK;SNN From The Last 14 Days
Check below for free stories on SYK;SNN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
08:19 EDTSYKLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
July 23, 2014
13:36 EDTSYKIntuitive Surgical rises after Q2 EPS, revenue beat expectations
Subscribe for More Information
July 22, 2014
08:36 EDTSYKStryker appoints CEO Kevin Lobo as chairman
Subscribe for More Information
July 18, 2014
09:00 EDTSYKStryker price target raised to $92 from $87 at RW Baird
Baird raised its price target on Stryker to $92 from $87 citing valuation, organic sales growth, and solid risk/reward. The firm has an Outperform rating on the stock.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use